Battle Biotech

Antiviral antisense therapeutics for neurodegeneration.

Battle Biotech is a research-stage biotechnology company developing RNA-interference (RNAi) therapeutics that target the viral drivers of Alzheimer’s disease and related neurodegeneration — aiming to treat the disease upstream, before irreversible damage.

Founded and led by CEO Dr. Richelle Cutler.

Explore

Programs

Herpesvirus Therapies

The therapeutic rationale, our issued and pending patents, and how the approach works.

View therapies →

Science

The Science & Research

The working hypothesis, the research programme, and Dr. Cutler’s background.

Explore the science →

Publication

Oskar Fischer Prize Entry

The full paper: herpesviruses as a non-genetic driver of Alzheimer’s disease.

Read the paper →

Evaluation

Scientific Analysis

An independent evaluation of the hypothesis, scored against the prize criteria.

Read the analysis →